Nrf2 and Her3 co-expression in cholangiocarcinoma: Possible biological pathways for potential therapeutic approach

被引：0
|
作者：
Parente, Paola [1 ]
Angerilli, Valentina [2 ]
Zamboni, Giuseppe [3 ]
Sparaneo, Angelo [4 ]
Fiordelisi, Fabiola [1 ]
Di Candia, Leonarda [1 ]
Fassan, Matteo [2 ,5 ]
Graziano, Paolo [1 ]
机构：
[1] Fdn IRCCS Casa Sollievo Sofferenza, Pathol Unit, I-71013 San Giovanni Rotondo, Foggia, Italy
[2] Univ Padua, Dept Med DIMED, Surg Pathol Unit, I-35128 Padua, Padua, Italy
[3] IRCCS Osped Sacro Cuore Don Calabria, Pathol Unit, I-37024 Negrar, Verona, Italy
[4] Fdn IRCCS Casa Sollievo Sofferenza, Lab Oncol, I-71013 San Giovanni Rotondo, Foggia, Italy
[5] IRCCS, Veneto Inst Oncol IOV, I-35124 Padua, Padua, Italy
来源：
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL | 2024年 / 23卷 / 03期
关键词：
OVEREXPRESSION;
D O I：
10.1016/j.hbpd.2023.02.010
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：317 / 321
页数：5
相关论文
共 50 条
  • [1] Nrf2 and Her3 co-expression in cholangiocarcinoma:Possible biological pathways for potential therapeutic approach
    Paola Parente
    Valentina Angerilli
    Giuseppe Zamboni
    Angelo Sparaneo
    Fabiola Fiordelisi
    Leonarda Di Candia
    Matteo Fassan
    Paolo Graziano
    Hepatobiliary & Pancreatic Diseases International, 2024, 23 (03) : 317 - 321
  • [2] Patterns of EGFR and HER3 co-expression in solid tumors
    Wood, Matthew
    Morrison, Cody
    Khalili, Jahan Salar
    Zhu, Yi
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Nrf2 in human cancers: biological significance and therapeutic potential
    Tian, Yu
    Tang, Lixin
    Wang, Xin
    Ji, Yanqin
    Tu, Yanyang
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (08): : 3935 - 3961
  • [4] The Dual Role of NRF2 in Colorectal Cancer: Targeting NRF2 as a Potential Therapeutic Approach
    Hu, Mengyun
    Yuan, Lingling
    Zhu, Jie
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 5985 - 6004
  • [5] NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies
    Khalil, Hilal S.
    Langdon, Simon P.
    Kankia, Ibrahim H.
    Bown, James
    Deeni, Yusuf Y.
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2016, 2016
  • [6] Co-expression of HER3 in HER2-positive metastatic breast cancer patients is an independent predictor of impaired prognosis
    Berghoff, A. S.
    Bago-Horvath, Z.
    Preusser, M.
    Steger, G. G.
    Rudas, M.
    Birner, P.
    Zielinski, C. C.
    Bartsch, R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S421 - S421
  • [7] Modulation of NRF2: Biological Dualism in Cancer, Targets and Possible Therapeutic Applications
    Gallorini, Marialucia
    Carradori, Simone
    Panieri, Emiliano
    Sova, Matej
    Saso, Luciano
    ANTIOXIDANTS & REDOX SIGNALING, 2024, 40 (10-12) : 636 - 662
  • [8] The role of the HER2 and HER3 in prostate cancer and their potential as therapeutic targets
    Rao, K.
    Gaughan, L.
    Robson, C.
    McCracken, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S177 - S177
  • [9] Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy
    Deliyanti, Devy
    Alrashdi, Saeed F.
    Tan, Sih Min
    Meyer, Colin
    Ward, Keith W.
    de Haan, Judy B.
    Wilkinson-Berka, Jennifer L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (02) : 815 - 825
  • [10] Co-expression of HER3 and MUC1 is associated with a favourable prognosis in patients with bladder cancer
    Nielsen, Trine O.
    Borre, Michael
    Nexo, Ebba
    Sorensen, Boe S.
    BJU INTERNATIONAL, 2015, 115 (01) : 163 - 165
12345